The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis.

MLA

Zhan, Ze-Jiang, et al. “The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis.” Frontiers in Immunology, vol. 12, Aug. 2021, p. 719650. EBSCOhost, https://doi.org/10.3389/fimmu.2021.719650.

APA

Zhan, Z.-J., Yao, W.-Y., Zhang, F., Qiu, W.-Z., Liao, K.-, Feng, J.-H., Tan, J.-Y., Liu, H., Yuan, T.-Z., Zheng, R.-H., & Yuan, Y.-W. (2021). The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis. Frontiers in Immunology, 12, 719650. https://doi.org/10.3389/fimmu.2021.719650

Chicago

Zhan, Ze-Jiang, Wen-Yu Yao, Fang Zhang, Wen-Ze Qiu, Kai- Liao, Jian-Hui Feng, Jin-Yun Tan, et al. 2021. “The Optimal Second-Line Systemic Treatment Model for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: A Bayesian Network Meta-Analysis.” Frontiers in Immunology 12 (August): 719650. doi:10.3389/fimmu.2021.719650.